Psoriatic arthritis

Anna Tumyan, Marcy B. Bolster

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Psoriatic arthritis is a chronic inflammatory arthritis associated with -psoriasis. Psoriatic arthritis belongs to the group of seronegative spondyloarthropathies and may present with both peripheral joint and axial skeleton involvement. In addition to joint and cutaneous disease, the other common features of psoriatic arthritis include dactylitis and enthesitis, resulting from involvement of surrounding tendons and ligaments as well as nail changes including pitting, ridging, and distal onycholysis. Familial aggregation of cases is common with HLA-B27 positivity reported in 10-25% of patients. There are no validated diagnostic criteria available for psoriatic arthritis and diagnosis should be based on the presence of characteristic clinical manifestations, physical examination, laboratory and imaging findings, and additionally, by the process of elimination of other common inflammatory -Arthritides. The treatment of patients presenting with more severe joint disease, unresponsive to nonsteroidal anti-inflammatory drugs (NSAIDs), extra-Articular manifestations and/or poor prognostic factors require use of systemic disease-modifying anti-rheumatic drugs (DMARDs) and/or biologic agents. Cases related to the presentation of the spectrum of psoriatic arthritis are discussed.

Original languageEnglish (US)
Title of host publicationChallenging Cases in Rheumatology and Diseases of the Immune System
PublisherSpringer New York
Pages55-69
Number of pages15
Volume9781461450887
ISBN (Electronic)9781461450887
ISBN (Print)146145087X, 9781461450870
DOIs
StatePublished - Mar 1 2013

Fingerprint

Psoriatic Arthritis
Antirheumatic Agents
Joint Diseases
Arthritis
Onycholysis
Joints
Spondylarthropathies
HLA-B27 Antigen
Biological Factors
Nails
Psoriasis
Ligaments
Skin Diseases
Skeleton
Tendons
Physical Examination
Anti-Inflammatory Agents
Pharmaceutical Preparations

Keywords

  • Inflammatory polyarthritis
  • Psoriasis
  • Psoriatic arthritis
  • Seronegative spondyloarthropathy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tumyan, A., & Bolster, M. B. (2013). Psoriatic arthritis. In Challenging Cases in Rheumatology and Diseases of the Immune System (Vol. 9781461450887, pp. 55-69). Springer New York. https://doi.org/10.1007/978-1-4614-5088-7_4

Psoriatic arthritis. / Tumyan, Anna; Bolster, Marcy B.

Challenging Cases in Rheumatology and Diseases of the Immune System. Vol. 9781461450887 Springer New York, 2013. p. 55-69.

Research output: Chapter in Book/Report/Conference proceedingChapter

Tumyan, A & Bolster, MB 2013, Psoriatic arthritis. in Challenging Cases in Rheumatology and Diseases of the Immune System. vol. 9781461450887, Springer New York, pp. 55-69. https://doi.org/10.1007/978-1-4614-5088-7_4
Tumyan A, Bolster MB. Psoriatic arthritis. In Challenging Cases in Rheumatology and Diseases of the Immune System. Vol. 9781461450887. Springer New York. 2013. p. 55-69 https://doi.org/10.1007/978-1-4614-5088-7_4
Tumyan, Anna ; Bolster, Marcy B. / Psoriatic arthritis. Challenging Cases in Rheumatology and Diseases of the Immune System. Vol. 9781461450887 Springer New York, 2013. pp. 55-69
@inbook{ff75adbef0634cd695a699fbfe83ddd0,
title = "Psoriatic arthritis",
abstract = "Psoriatic arthritis is a chronic inflammatory arthritis associated with -psoriasis. Psoriatic arthritis belongs to the group of seronegative spondyloarthropathies and may present with both peripheral joint and axial skeleton involvement. In addition to joint and cutaneous disease, the other common features of psoriatic arthritis include dactylitis and enthesitis, resulting from involvement of surrounding tendons and ligaments as well as nail changes including pitting, ridging, and distal onycholysis. Familial aggregation of cases is common with HLA-B27 positivity reported in 10-25{\%} of patients. There are no validated diagnostic criteria available for psoriatic arthritis and diagnosis should be based on the presence of characteristic clinical manifestations, physical examination, laboratory and imaging findings, and additionally, by the process of elimination of other common inflammatory -Arthritides. The treatment of patients presenting with more severe joint disease, unresponsive to nonsteroidal anti-inflammatory drugs (NSAIDs), extra-Articular manifestations and/or poor prognostic factors require use of systemic disease-modifying anti-rheumatic drugs (DMARDs) and/or biologic agents. Cases related to the presentation of the spectrum of psoriatic arthritis are discussed.",
keywords = "Inflammatory polyarthritis, Psoriasis, Psoriatic arthritis, Seronegative spondyloarthropathy",
author = "Anna Tumyan and Bolster, {Marcy B.}",
year = "2013",
month = "3",
day = "1",
doi = "10.1007/978-1-4614-5088-7_4",
language = "English (US)",
isbn = "146145087X",
volume = "9781461450887",
pages = "55--69",
booktitle = "Challenging Cases in Rheumatology and Diseases of the Immune System",
publisher = "Springer New York",

}

TY - CHAP

T1 - Psoriatic arthritis

AU - Tumyan, Anna

AU - Bolster, Marcy B.

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Psoriatic arthritis is a chronic inflammatory arthritis associated with -psoriasis. Psoriatic arthritis belongs to the group of seronegative spondyloarthropathies and may present with both peripheral joint and axial skeleton involvement. In addition to joint and cutaneous disease, the other common features of psoriatic arthritis include dactylitis and enthesitis, resulting from involvement of surrounding tendons and ligaments as well as nail changes including pitting, ridging, and distal onycholysis. Familial aggregation of cases is common with HLA-B27 positivity reported in 10-25% of patients. There are no validated diagnostic criteria available for psoriatic arthritis and diagnosis should be based on the presence of characteristic clinical manifestations, physical examination, laboratory and imaging findings, and additionally, by the process of elimination of other common inflammatory -Arthritides. The treatment of patients presenting with more severe joint disease, unresponsive to nonsteroidal anti-inflammatory drugs (NSAIDs), extra-Articular manifestations and/or poor prognostic factors require use of systemic disease-modifying anti-rheumatic drugs (DMARDs) and/or biologic agents. Cases related to the presentation of the spectrum of psoriatic arthritis are discussed.

AB - Psoriatic arthritis is a chronic inflammatory arthritis associated with -psoriasis. Psoriatic arthritis belongs to the group of seronegative spondyloarthropathies and may present with both peripheral joint and axial skeleton involvement. In addition to joint and cutaneous disease, the other common features of psoriatic arthritis include dactylitis and enthesitis, resulting from involvement of surrounding tendons and ligaments as well as nail changes including pitting, ridging, and distal onycholysis. Familial aggregation of cases is common with HLA-B27 positivity reported in 10-25% of patients. There are no validated diagnostic criteria available for psoriatic arthritis and diagnosis should be based on the presence of characteristic clinical manifestations, physical examination, laboratory and imaging findings, and additionally, by the process of elimination of other common inflammatory -Arthritides. The treatment of patients presenting with more severe joint disease, unresponsive to nonsteroidal anti-inflammatory drugs (NSAIDs), extra-Articular manifestations and/or poor prognostic factors require use of systemic disease-modifying anti-rheumatic drugs (DMARDs) and/or biologic agents. Cases related to the presentation of the spectrum of psoriatic arthritis are discussed.

KW - Inflammatory polyarthritis

KW - Psoriasis

KW - Psoriatic arthritis

KW - Seronegative spondyloarthropathy

UR - http://www.scopus.com/inward/record.url?scp=84949175378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949175378&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-5088-7_4

DO - 10.1007/978-1-4614-5088-7_4

M3 - Chapter

SN - 146145087X

SN - 9781461450870

VL - 9781461450887

SP - 55

EP - 69

BT - Challenging Cases in Rheumatology and Diseases of the Immune System

PB - Springer New York

ER -